Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back To Search Results
Device Classification Name Cardiac Allograft Gene Expression Profiling Test System
510(k) Number K221640
Device Name AlloMap Heart Molecular Expression Testing
Applicant
CareDx, Inc.
3260 Bayshore Boulevard
Brisbane,  CA  94005
Applicant Contact Camilla Lu
Correspondent
CareDx, Inc.
3260 Bayshore Boulevard
Brisbane,  CA  94005
Correspondent Contact Camilla Lu
Regulation Number862.1163
Classification Product Code
OJQ  
Date Received06/06/2022
Decision Date 09/13/2023
Decision Substantially Equivalent (SESE)
Regulation Medical Specialty Cardiovascular
510k Review Panel Clinical Chemistry
Summary Summary
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Combination Product No
-
-